Collegium Pharmaceutical Inc (COLL) reports a 31% revenue surge and raises 2025 guidance, driven by strong performance in its pain portfolio and Jornay PM.

Ford’s November 2025 lease deals are particularly enticing. The monthly repayments are competitive, the mileage allowances ...